| HOME >> BIOLOGY >> TECHNOLOGY |
Deferred income taxes 542 294 46 6
Convertible notes issuance
costs 38,020 35,447 32,898 4,391
Total assets 3,192,228 3,151,995 3,121,650 416,620
Liabilities
Current liabilities
Trade accounts payable 47,847 55,499 47,036 6,277
Accrued liabilities and other
payables 594,489 519,555 510,938 68,191
Income tax payable 38,467 39,252 43,731 5,836
Dividend payable -- 83,306 -- --
Total current liabilities 680,803 697,612 601,705 80,304
Convertible notes 1,158,480 1,141,800 1,123,920 150,000
Other payable - long term 67,206 67,794 67,902 9,062
Total liabilities 1,906,489 1,907,206 1,793,527 239,366
Shareholders' equity
Ordinary shares
US$0.1 par value: 500,000,000
authorized; 273,600,001
issued and outstanding as
of March 31, 2007 and June
30, 2007 and 274,000,001
issued and outstanding as
of September 30, 2007 225,125 225,125 225,425 30,086
Additional paid-in capital 504,795 506,174 515,909 68,854
Accumulated other
comprehensive loss (21,335) (25,181) (29,267) (3,906)
Retained earnings 577,154 538,671 616,056 82,220
Total shareholders' equity 1,285,739 1,244,789 1,328,123 177,254
Total liabilities and
shareholders' equity 3,192,228 3,151,995 3,121,650 416,620
Note:
(1) Adjustments have been made to restate certain numbers including the
increase in intangible assets and relevant amortization, the
'/>"/>
| SOURCE China Medical Technologies, Inc. Copyright©2007 PR Newswire. All rights reserved |